TY  - GEN
AU  - Duran,Jason M
AU  - Makarewich,Catherine A
AU  - Trappanese,Danielle
AU  - Gross,Polina
AU  - Husain,Sharmeen
AU  - Dunn,Jonathan
AU  - Lal,Hind
AU  - Sharp,Thomas E
AU  - Starosta,Timothy
AU  - Vagnozzi,Ronald J
AU  - Berretta,Remus M
AU  - Barbe,Mary
AU  - Yu,Daohai
AU  - Gao,Erhe
AU  - Kubo,Hajime
AU  - Force,Thomas
AU  - Houser,Steven R
TI  - Sorafenib cardiotoxicity increases mortality after myocardial infarction
SN  - 1524-4571
PY  - 2014///0714
KW  - Animals
KW  - Antineoplastic Agents
KW  - adverse effects
KW  - Apoptosis
KW  - drug effects
KW  - Cats
KW  - Cell Proliferation
KW  - Cells, Cultured
KW  - Disease Models, Animal
KW  - Dose-Response Relationship, Drug
KW  - Heart
KW  - In Vitro Techniques
KW  - Male
KW  - Metoprolol
KW  - pharmacology
KW  - Mice
KW  - Mice, Inbred C57BL
KW  - Myocardial Infarction
KW  - mortality
KW  - Myocytes, Cardiac
KW  - Niacinamide
KW  - Phenylurea Compounds
KW  - Proto-Oncogene Proteins c-kit
KW  - Sorafenib
N1  - Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1161/CIRCRESAHA.114.303200
ER  -